Therapeutics Initiative

Last updated

History

The Therapeutics Initiative was founded in 1994 by the British Columbia Ministry of Health. [1] Since 2013, the organization has been managed by the UBC. [3]

When requested it additionally looks at specific medications to generate reports for PharmaCare. [1] These reports are generated without look at costs just medication effects. [1] This is done independently of the pharmaceutical industry and government. [4]

They additionally publish the "Therapeutics Letter" [4] and are part of the International Society of Drug Bulletins. [5]

Controversy

In 2008, a pharmaceutical task force established by the British Columbia government published a report on the Therapeutics Initiative. [4] The task force members included Russell Williams who was then head of Canada’s Research-Based Pharmaceutical Companies (Rx&D) and employees of Angiotech Pharmaceuticals. [4] They recommended closing the TI. [4]

See also

References

  1. 1 2 3 4 Bassett, Ken (May 2006). "Therapeutics Initiative--role and function". BCMJ. 40 (4): 163.
  2. ↑ Kaufert, P; Kaufert, J (15 July 2008). "Distressing news on the Therapeutics Initiative". Canadian Medical Association Journal. 179 (2): 164. doi:10.1503/cmaj.1080074. PMC   2443219 . PMID   18625994.
  3. ↑ Webster, PC (11 June 2013). "UBC takes over Therapeutics Initiative after provincial cuts". Canadian Medical Association Journal. 185 (9): 758. doi:10.1503/cmaj.109-4485. PMC   3680554 . PMID   23649419.
  4. 1 2 3 4 5 Silversides, A (1 July 2008). "Highly lauded drug assessment program under attack". Canadian Medical Association Journal. 179 (1): 26–7. doi:10.1503/cmaj.080845. PMC   2464479 . PMID   18509096.
  5. ↑ "Therapeutics Letter" . Retrieved 25 December 2015.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.